Literature DB >> 26636517

Clinical significance of serum procalcitonin level monitoring on early diagnosis of severe pneumonia on children.

F Zhu1, Z Jiang, W H Li, H Y Wei, G D Su.   

Abstract

OBJECTIVE: To discuss the method for early diagnosis of severe pneumonia on children. PATIENTS AND METHODS: Fifty-six children with severe pneumonia were enrolled from Department of Pediatrics and Intensive Care Unit (ICU) of our hospital and divided into two groups according to parasitological detection: bacterial pneumonia group consisting of 34 children patients and non-bacterial pneumonia group of 32 children patients. In the meanwhile, 37 healthy children, who were confirmed without infection through physical examination, were also enrolled and grouped in into normal control group. Peripheral venous blood of all children was collected to detect their procalcitonin (PCT).
RESULTS: PCT level of patients in bacterial pneumonia group was significantly higher than that in the non-bacterial pneumonia group and control group, and difference had statistical significance (p < 0.01); serum PCT level on patients in bacterial pneumonia group before and after treatment had statistical significance (p < 0.01); serum PCT level on patients in non-bacterial pneumonia group before and after treatment had no statistical significance (p > 0.05).
CONCLUSIONS: PCT was a very important biomarker for the diagnosis of bacterial infection and also a sensitive indicator for the distinction of child bacterial pneumonia and non-bacterial pneumonia. It had significant clinical diagnosis and differential diagnosis value.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26636517

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  C/MIC &gt; 4: A Potential Instrument to Predict the Efficacy of Meropenem.

Authors:  Yichang Zhao; Chenlin Xiao; Jingjing Hou; Jiamin Wu; Yiwen Xiao; Bikui Zhang; Indy Sandaradura; Hong Luo; Jinhua Li; Miao Yan
Journal:  Antibiotics (Basel)       Date:  2022-05-16

2.  Role of procalcitonin in diagnosis of community acquired pneumonia in Children.

Authors:  Vinod H Ratageri; Puspha Panigatti; Aparna Mukherjee; Rashmi R Das; Jagdish Prasad Goyal; Javeed Iqbal Bhat; Bhadresh Vyas; Rakesh Lodha; Deepak Singhal; Prawin Kumar; Kuldeep Singh; Samarendra Mahapatro; Bashir Ahmad Charoo; S K Kabra; K R Jat
Journal:  BMC Pediatr       Date:  2022-04-20       Impact factor: 2.567

Review 3.  Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review.

Authors:  Anokhi J Kapasi; Sabine Dittrich; Iveth J González; Timothy C Rodwell
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 4.  Biomarkers in Pediatric Community-Acquired Pneumonia.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-19       Impact factor: 5.923

5.  Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis.

Authors:  Yu Liu; Weize Yang; Jie Wei
Journal:  Iran J Public Health       Date:  2017-11       Impact factor: 1.429

6.  Usefulness of the procalcitonin test in young febrile infants between 1 and 3 months of age.

Authors:  In Sul Lee; Young Jin Park; Mi Hyeon Jin; Ji Young Park; Hae Jeong Lee; Sung Hoon Kim; Ju Suk Lee; Cheol Hong Kim; Young Don Kim; Jun Hwa Lee
Journal:  Korean J Pediatr       Date:  2018-09-15

7.  Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia.

Authors:  Wenlong Wang; Yitang Zhu; Linlin Yin; Yaoyao Deng; Guoxian Chu; Supin Liu
Journal:  Mol Cell Biochem       Date:  2020-09-29       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.